Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
Sotera Health (NASDAQ: SHC) announced that company management will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Sotera Health (NASDAQ: SHC) announced that company management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 1:30 p.m. ET / 10:30 a.m. PT.
Company representatives will also hold investor meetings during the conference. A live webcast and accompanying materials will be posted on the company's Investor Relations website, and a replay will be available within 48 hours and remain archived on the site.
Details
News Market Reaction – SHC
On Jan 7, the day this news came out, SHC closed 0.37% above the previous close.
Data tracked by StockTitan Argus for the Jan 7 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 12, 2026
- Scheduled conference presentation
- Presentation time ET
- 1:30 p.m. Eastern Time
- Conference session start
- Presentation time PT
- 10:30 a.m. Pacific Time
- Conference session start
- Replay availability
- 48 hours
- Timeframe for posting replay after presentation
Historical Context
-
Large sponsor-led secondary sale without proceeds to the company.
-
Strong Q3 2025 results and raised EBITDA outlook.
-
Announcement of Q3 2025 release date and conference call details.
-
20M-share secondary sale by Warburg Pincus and GTCR affiliates.
-
Strong Q2 2025 growth and raised full-year outlook.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CLEVELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. Company representatives will also participate in investor meetings during the conference.
A live webcast of the presentation, along with accompanying materials, will be available on the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay will be available within 48 hours following the presentation and will remain archived on the Company's website.
About Sotera Health:
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates on matters relevant to investors are available in the Investor Relations section of our website at Investor Relations | Sotera Health. Developments related to Ethylene Oxide are available at Ethylene Oxide | Sotera Health.
INVESTOR RELATIONS CONTACTS:
Jason Peterson
Vice President, Investor Relations
IR@soterahealth.com
MEDIA CONTACT:
Kristin Gibbs
Chief Marketing Officer
kgibbs@soterahealth.com
Source: Sotera Health Company
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.